These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3986814)

  • 41. Enhancer dysfunction in leukemia.
    Bhagwat AS; Lu B; Vakoc CR
    Blood; 2018 Apr; 131(16):1795-1804. PubMed ID: 29439951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic changes of non-small cell lung cancer under neoadjuvant therapy.
    Warth A; Endris V; Stenzinger A; Penzel R; Harms A; Duell T; Abdollahi A; Lindner M; Schirmacher P; Muley T; Dienemann H; Fink L; Morresi-Hauf A; Pfarr N; Weichert W
    Oncotarget; 2016 May; 7(20):29761-9. PubMed ID: 27105513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.
    Liu LL; Li F; Pao W; Michor F
    PLoS One; 2015; 10(11):e0141665. PubMed ID: 26536620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surviving childhood cancer: the impact on life.
    Goldsby RE; Taggart DR; Ablin AR
    Paediatr Drugs; 2006; 8(2):71-84. PubMed ID: 16608369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells.
    Hakoda M; Hirai Y; Akiyama M; Yamanaka H; Terai C; Kamatani N; Kashiwazaki S
    Hum Genet; 1995 Dec; 96(6):674-80. PubMed ID: 8522326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of sizofiran on anticancer agent- or X-ray-induced sister chromatid exchanges and mitotic block in murine bone marrow cells.
    Yang ZB; Tsuchiya Y; Arika T; Hosokawa M
    Jpn J Cancer Res; 1993 May; 84(5):538-43. PubMed ID: 8320171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
    Albertini RJ; Nicklas JA; Fuscoe JC; Skopek TR; Branda RF; O'Neill JP
    Environ Health Perspect; 1993 Mar; 99():135-41. PubMed ID: 8319611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic cell gene mutations in humans: biomarkers for genotoxicity.
    Albertini RJ; Nicklas JA; O'Neill JP
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):193-201. PubMed ID: 8143616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus.
    Langlois RG; Bigbee WL; Jensen RH
    Hum Genet; 1986 Dec; 74(4):353-62. PubMed ID: 3793098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory.
    Yanagida J; Hozawa S; Ishioka S; Maeda H; Takahashi K; Oyama T; Takaishi M; Hakoda M; Akiyama M; Yamakido M
    Jpn J Cancer Res; 1988 Dec; 79(12):1276-83. PubMed ID: 3148597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer.
    van den Berg-de Ruiter E; de Jong B; Mulder NH; te Meerman GJ; Schraffordt Koops H; Sleijfer DT
    Hum Genet; 1990 Jan; 84(2):191-4. PubMed ID: 2298456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human somatic mutation assays as biomarkers of carcinogenesis.
    Compton PJ; Hooper K; Smith MT
    Environ Health Perspect; 1991 Aug; 94():135-41. PubMed ID: 1954924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fine structure mapping of the hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene region of the human X chromosome (Xq26).
    Nicklas JA; Hunter TC; O'Neill JP; Albertini RJ
    Am J Hum Genet; 1991 Aug; 49(2):267-78. PubMed ID: 1678246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The assessment of in vivo somatic mutations in survivors of childhood malignancy.
    Hewitt M; Mott MG
    Br J Cancer; 1992 Jul; 66(1):143-7. PubMed ID: 1637665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased mutation frequency following treatment with cancer chemotherapy.
    Dempsey JL; Seshadri RS; Morley AA
    Cancer Res; 1985 Jun; 45(6):2873-7. PubMed ID: 3986814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second neoplasms following radiotherapy or chemotherapy for cancer.
    Penn I
    Am J Clin Oncol; 1982 Feb; 5(1):83-96. PubMed ID: 7081142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis of HPRT mutant frequency in children with cancer.
    Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
    Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy.
    Karnaoukhova L; Moffat J; Martins H; Glickman B
    Cancer Res; 1997 Oct; 57(19):4393-407. PubMed ID: 9331103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
    Dührsen U
    Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.